Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Prof John Robertson - University of Nottingham, UK
Prof John Robertson - University of Nottingham, UK
Prof John Robertson - University of Nottingham,  UK
Report
Prof John Robertson - University of Nottingham, UK
Prof Robertson talks to ecancertv at the 2010 San Antonio Breast Cancer Symposium about fulvestrant (500mg dose) in comparison to the aromatase inhibitor, anastrozole, when used as a first-line treatment for hormone receptor positive breast cancer. Follow-up data from the FIRST (FASLODEX fIRst line Study comparing endocrine Treatments) trial - a randomised, open-label, phase II trial in postmenopausal women with locally advanced or metastatic disease - showed a 34% reduction in risk of progression with fulvestrant 500mg compared with anastrozole. Prof Robertson considers impact in the clinic and potential future research.
Channel: www.ecancer.tv
Category: Science
Video Length: 0
Date Found: February 01, 2011
Date Produced:
View Count: 2
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.